CRM is up 25% on the week and 40% over the past month, yet options traders have not stood down — and that tension carries into the next earnings date on September 16.
The analyst community has moved decisively more constructive since the August 26 earnings beat. More than ten firms raised price targets in the days immediately following, and the activity has continued into this week. Cantor Fitzgerald lifted its target to $300 from $250. TD Cowen went to $300 from $280. Needham reiterated Buy with a $400 target — the most bullish on the board by a wide margin. JP Morgan raised to $265 from $250, keeping Overweight. Citigroup, staying Neutral, moved its target to $233 from $204. The mean consensus target now sits at $269.48 against a $258.11 close, implying modest upside at current levels. Crucially, not one firm upgraded its rating. Every action is a target raise on a maintained conviction — the Street is following the stock rather than leading it.
The options market tells a more guarded story. Put/call ratio is running at 0.997, nearly two standard deviations above its 20-day average of 0.874. That reading is within a whisker of the 52-week high of 1.016 touched on August 28. Defensive positioning has actually persisted and deepened through the post-earnings rally — options traders are hedging into the next catalyst, not celebrating the last one. Previous notes flagged this tension on August 28; it has not resolved. The PCR z-score of 1.96 keeps the setup firmly in elevated-caution territory.
Short positioning, by contrast, has collapsed. SI dropped 20% on the week to 2.68% of free float — the lowest level in the 30-day data window, down from roughly 5% in late July. Borrow availability is now exceptionally loose at 6,593% of short interest, with over 553 million shares available to lend against just 25.5 million shorted. Cost to borrow is 0.36%, barely above zero. The ORTEX short score has eased to 32.5, down from 35.4 two weeks ago. Bears have largely exited. What remains of short interest looks like residual positioning rather than a crowded thesis.
The earnings history is relevant context. The August 26 print delivered a one-day move of +22.5%. The next event is scheduled for September 16 — less than two weeks away. With shorts gone, bull cases anchored in AI expansion and CRM leadership, and analysts uniformly raising targets without upgrading ratings, the upcoming print becomes a test of whether the stock's 40% one-month move has already priced the good news. Peer enterprise software names have had a rougher week: NOW fell 3.4% on the day, CXM dropped 7.4%, and PATH slid 2.8% — all underperforming CRM's flat-to-positive session, which suggests the post-earnings premium is still holding relative to the group.
The setup into September 16 is one where the bears are gone, the analysts are constructive but not upgrading, and options traders are the most defensively positioned they have been all year — watch whether that put demand fades or firms as the earnings date approaches.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
